がん治療薬の世界市場

QYResearchが発行した調査報告書(QYR802A0942)
◆英語タイトル:Global Cancer Treatment Drugs Market Research Report 2018
◆商品コード:QYR802A0942
◆発行会社(リサーチ会社):QYResearch
◆発行日:2018年1月9日
◆ページ数:125
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療・バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,900 ⇒換算¥313,200見積依頼/購入/質問フォーム
Enterprise(同一法人内共有可)USD5,800 ⇒換算¥626,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

当調査レポートでは、世界のがん治療薬市場について調査・分析し、がん治療薬の世界市場概観、がん治療薬の種類別市場分析、用途別市場分析、がん治療薬の世界市場規模予測、関連企業分析、主要地域別分析(北米市場、ヨーロッパ市場、中国市場、日本市場、アジア市場など)、関連企業情報、価格情報、販売動向、市場動向、貿易動向、市場環境分析情報などを含め、以下の構成でお届けいたします。

・がん治療薬の世界市場概観
・がん治療薬の種類別市場規模
・がん治療薬の用途別市場規模
・がん治療薬の世界市場規模
・がん治療薬の世界市場規模予測
・がん治療薬の主要地域別市場規模
・がん治療薬の北米市場規模・予測
・がん治療薬のヨーロッパ市場規模・予測
・がん治療薬の中国市場規模・予測
・がん治療薬の日本市場規模・予測
・がん治療薬のアジア市場規模・予測
・がん治療薬の製造メーカー分析
・がん治療薬のメーカー別生産量
・がん治療薬のメーカー別市場シェア
・がん治療薬の価格動向・価格分析
・がん治療薬の販売(売上高)動向
・がん治療薬の貿易(輸出・輸入)動向
・がん治療薬の産業チェーン分析
・がん治療薬のマーケティング戦略分析
・がん治療薬の販売業者(代理店)リスト
・がん治療薬の市場環境分析
...
【レポートの概要】

In this report, the global Cancer Treatment Drugs market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Cancer Treatment Drugs in these regions, from 2013 to 2025 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India
Global Cancer Treatment Drugs market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Roche (Switzerland)
Novartis (Switzerland)
Celgene (U.S.)
Amgen (U.S.)
Johnson & Johnson (U.S.)
Bristol-Myers Squibb (U.S.)
Takeda (Japan)
Eli Lilly (U.S.)
Pfizer (U.S.)
AstraZeneca (Sweden)
Astellas (Japan)
Sanofi (France)
Bayer (Germany)
Merck & Co. (U.S.)
Biogen Idec (U.S.)
Kyowa Hakko Kirin (Japan)
Otsuka (Japan)
Teva (Israel)
Eisai (Japan)
Merck KGaA (Germany)
Ipsen (France)
AbbVie (U.S.)
Gilead Sciences (U.S.)
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Chemotherapy
Targeted Therapy
Immunotherapy
Hormonal Therapy (Biologic Therapy)
Others
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory/Lung Cancer
Other Cancers

If you have any special requirements, please let us know and we will offer you the report as you want.

【レポートの目次】

Table of Contents

Global Cancer Treatment Drugs Market Research Report 2018
1 Cancer Treatment Drugs Market Overview
1.1 Product Overview and Scope of Cancer Treatment Drugs
1.2 Cancer Treatment Drugs Segment by Type (Product Category)
1.2.1 Global Cancer Treatment Drugs Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
1.2.2 Global Cancer Treatment Drugs Production Market Share by Type (Product Category) in 2017
1.2.3 Chemotherapy
1.2.4 Targeted Therapy
1.2.5 Immunotherapy
1.2.6 Hormonal Therapy (Biologic Therapy)
1.2.7 Others
1.3 Global Cancer Treatment Drugs Segment by Application
1.3.1 Cancer Treatment Drugs Consumption (Sales) Comparison by Application (2013-2025)
1.3.2 Blood Cancer
1.3.3 Breast Cancer
1.3.4 Gastrointestinal Cancer
1.3.5 Prostate Cancer
1.3.6 Respiratory/Lung Cancer
1.3.7 Other Cancers
1.4 Global Cancer Treatment Drugs Market by Region (2013-2025)
1.4.1 Global Cancer Treatment Drugs Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
1.4.2 North America Status and Prospect (2013-2025)
1.4.3 Europe Status and Prospect (2013-2025)
1.4.4 China Status and Prospect (2013-2025)
1.4.5 Japan Status and Prospect (2013-2025)
1.4.6 Southeast Asia Status and Prospect (2013-2025)
1.4.7 India Status and Prospect (2013-2025)
1.5 Global Market Size (Value) of Cancer Treatment Drugs (2013-2025)
1.5.1 Global Cancer Treatment Drugs Revenue Status and Outlook (2013-2025)
1.5.2 Global Cancer Treatment Drugs Capacity, Production Status and Outlook (2013-2025)

2 Global Cancer Treatment Drugs Market Competition by Manufacturers
2.1 Global Cancer Treatment Drugs Capacity, Production and Share by Manufacturers (2013-2018)
2.1.1 Global Cancer Treatment Drugs Capacity and Share by Manufacturers (2013-2018)
2.1.2 Global Cancer Treatment Drugs Production and Share by Manufacturers (2013-2018)
2.2 Global Cancer Treatment Drugs Revenue and Share by Manufacturers (2013-2018)
2.3 Global Cancer Treatment Drugs Average Price by Manufacturers (2013-2018)
2.4 Manufacturers Cancer Treatment Drugs Manufacturing Base Distribution, Sales Area and Product Type
2.5 Cancer Treatment Drugs Market Competitive Situation and Trends
2.5.1 Cancer Treatment Drugs Market Concentration Rate
2.5.2 Cancer Treatment Drugs Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Cancer Treatment Drugs Capacity, Production, Revenue (Value) by Region (2013-2018)
3.1 Global Cancer Treatment Drugs Capacity and Market Share by Region (2013-2018)
3.2 Global Cancer Treatment Drugs Production and Market Share by Region (2013-2018)
3.3 Global Cancer Treatment Drugs Revenue (Value) and Market Share by Region (2013-2018)
3.4 Global Cancer Treatment Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.5 North America Cancer Treatment Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.6 Europe Cancer Treatment Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.7 China Cancer Treatment Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.8 Japan Cancer Treatment Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.9 Southeast Asia Cancer Treatment Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.10 India Cancer Treatment Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

4 Global Cancer Treatment Drugs Supply (Production), Consumption, Export, Import by Region (2013-2018)
4.1 Global Cancer Treatment Drugs Consumption by Region (2013-2018)
4.2 North America Cancer Treatment Drugs Production, Consumption, Export, Import (2013-2018)
4.3 Europe Cancer Treatment Drugs Production, Consumption, Export, Import (2013-2018)
4.4 China Cancer Treatment Drugs Production, Consumption, Export, Import (2013-2018)
4.5 Japan Cancer Treatment Drugs Production, Consumption, Export, Import (2013-2018)
4.6 Southeast Asia Cancer Treatment Drugs Production, Consumption, Export, Import (2013-2018)
4.7 India Cancer Treatment Drugs Production, Consumption, Export, Import (2013-2018)

5 Global Cancer Treatment Drugs Production, Revenue (Value), Price Trend by Type
5.1 Global Cancer Treatment Drugs Production and Market Share by Type (2013-2018)
5.2 Global Cancer Treatment Drugs Revenue and Market Share by Type (2013-2018)
5.3 Global Cancer Treatment Drugs Price by Type (2013-2018)
5.4 Global Cancer Treatment Drugs Production Growth by Type (2013-2018)

6 Global Cancer Treatment Drugs Market Analysis by Application
6.1 Global Cancer Treatment Drugs Consumption and Market Share by Application (2013-2018)
6.2 Global Cancer Treatment Drugs Consumption Growth Rate by Application (2013-2018)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries

7 Global Cancer Treatment Drugs Manufacturers Profiles/Analysis
7.1 Roche (Switzerland)
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Cancer Treatment Drugs Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Roche (Switzerland) Cancer Treatment Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.1.4 Main Business/Business Overview
7.2 Novartis (Switzerland)
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Cancer Treatment Drugs Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Novartis (Switzerland) Cancer Treatment Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.2.4 Main Business/Business Overview
7.3 Celgene (U.S.)
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Cancer Treatment Drugs Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Celgene (U.S.) Cancer Treatment Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.3.4 Main Business/Business Overview
7.4 Amgen (U.S.)
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Cancer Treatment Drugs Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Amgen (U.S.) Cancer Treatment Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.4.4 Main Business/Business Overview
7.5 Johnson & Johnson (U.S.)
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Cancer Treatment Drugs Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Johnson & Johnson (U.S.) Cancer Treatment Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.5.4 Main Business/Business Overview
7.6 Bristol-Myers Squibb (U.S.)
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Cancer Treatment Drugs Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Bristol-Myers Squibb (U.S.) Cancer Treatment Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.6.4 Main Business/Business Overview
7.7 Takeda (Japan)
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Cancer Treatment Drugs Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Takeda (Japan) Cancer Treatment Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.7.4 Main Business/Business Overview
7.8 Eli Lilly (U.S.)
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Cancer Treatment Drugs Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Eli Lilly (U.S.) Cancer Treatment Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.8.4 Main Business/Business Overview
7.9 Pfizer (U.S.)
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Cancer Treatment Drugs Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Pfizer (U.S.) Cancer Treatment Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.9.4 Main Business/Business Overview
7.10 AstraZeneca (Sweden)
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Cancer Treatment Drugs Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 AstraZeneca (Sweden) Cancer Treatment Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.10.4 Main Business/Business Overview
7.11 Astellas (Japan)
7.12 Sanofi (France)
7.13 Bayer (Germany)
7.14 Merck & Co. (U.S.)
7.15 Biogen Idec (U.S.)
7.16 Kyowa Hakko Kirin (Japan)
7.17 Otsuka (Japan)
7.18 Teva (Israel)
7.19 Eisai (Japan)
7.20 Merck KGaA (Germany)
7.21 Ipsen (France)
7.22 AbbVie (U.S.)
7.23 Gilead Sciences (U.S.)

8 Cancer Treatment Drugs Manufacturing Cost Analysis
8.1 Cancer Treatment Drugs Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Cancer Treatment Drugs

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Cancer Treatment Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Cancer Treatment Drugs Major Manufacturers in 2017
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 Global Cancer Treatment Drugs Market Forecast (2018-2025)
12.1 Global Cancer Treatment Drugs Capacity, Production, Revenue Forecast (2018-2025)
12.1.1 Global Cancer Treatment Drugs Capacity, Production and Growth Rate Forecast (2018-2025)
12.1.2 Global Cancer Treatment Drugs Revenue and Growth Rate Forecast (2018-2025)
12.1.3 Global Cancer Treatment Drugs Price and Trend Forecast (2018-2025)
12.2 Global Cancer Treatment Drugs Production, Consumption , Import and Export Forecast by Region (2018-2025)
12.2.1 North America Cancer Treatment Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.2 Europe Cancer Treatment Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.3 China Cancer Treatment Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.4 Japan Cancer Treatment Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.5 Southeast Asia Cancer Treatment Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.6 India Cancer Treatment Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.3 Global Cancer Treatment Drugs Production, Revenue and Price Forecast by Type (2018-2025)
12.4 Global Cancer Treatment Drugs Consumption Forecast by Application (2018-2025)

13 Research Findings and Conclusion

14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer



【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ がん治療薬の世界市場(Global Cancer Treatment Drugs Market Research Report 2018)]についてメールでお問い合わせはこちらでお願いします。